22 / 64
20
SCIENTIFIC PROGRAMME
| PROGRAMME & EXHIBITION GUIDE
Interactive tumour board session
Limited T4a larynx cancer
14:15 - 15:15 | Auditorium
Chair: H.E. Eckel (Austria)
Panellists: A. Castro (Portugal)
J.G. Eriksen (Denmark)
W. Golusinski (Poland)
A. Argiris (Greece)
S. Tribius (Germany)
D. Chevalier (France)
Poster discussion
Poster discussion
15:15 - 16:00 | Auditorium
Chair: C. Simon (Switzerland)
Correlation and prognostic impact of HPV and p16 on RT-
outcome in larynx and hypopharynx cancer
P. Lassen (Denmark), M. Schou, J. Overgaard, J. Alsner
PD-026
cfHPV DNA as a marker of treatment results in patients with
HPV-related head and neck cancer
T. Rutkowski (Poland), A. Mazurek, M. Snietura, A. Wygoda,
M. Kentnowski, P. Polanowski, U. Dworzecka, B. Pilecki,
K. Dębiec, I. Gawron, J. Niedziałek, W. Pigłowski, U. Bojko,
P. Widłak, K. Składowski
PD-027
Prognostic and predictive impact of HPV status in oropharyngeal
cancer: the MARCH-HPV project
B. Lacas (France), P. Lassen, A. Trotti, B. Zackrisson, Q. Zhang,
J.P. Pignon, J. Overgaard, P. Blanchard
PD-028
15:15 Discussant: J. Hess (Germany)
Causes-of-death underestimate the burden of head and neck
cancers in France (EPICORL study)
Y. Pointreau (France), L. Sagaon Teyssier, L. Geoffrois, M. Bec,